SCHEMBL1961718

SCHEMBL1961718

CCCCCCCCCCCCCCCC(=O)C(C)(CN)S(=O)(=O)O.[NaH]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 11/20 0.46
▸ CES1 P23141 10/20 0.46
▸ CES2 O00748 5/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ PPARG P37231 3/20 0.38
▸ PPARD Q03181 3/20 0.38
▸ PPARA Q07869 3/20 0.38
▸ TSHR P16473 2/20 0.38
▸ GPR84 Q9NQS5 2/20 0.38
▸ HDAC11 Q96DB2 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ SLC22A6 Q4U2R8 1/20 0.38
▸ SLC22A8 Q8TCC7 1/20 0.38
▸ TLR2 O60603 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ FABP4 P15090 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1959306 1.00 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL1337430 1.00 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL1962801 1.00 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL413338 0.98 FAAH (0.47) FAAHCES1CES2MEN1KMT2A
SCHEMBL413335 0.98 FAAH (0.47) FAAHCES1CES2MEN1KMT2A
SCHEMBL410606 0.98 FAAH (0.47) FAAHCES1CES2MEN1KMT2A
SCHEMBL412965 0.98 FAAH (0.47) FAAHCES1CES2MEN1KMT2A
SCHEMBL2913821 0.97 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL22325578 0.97 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL2912760 0.97 FAAH (0.46) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119970527-A Liposome-containing composition for cosmetics 富士胶片株式会社 2025-05-13 — — CN disclosed
CN-115120509-A Liposome composition for cosmetic 富士胶片株式会社 2022-09-30 — — CN disclosed
EP-3443951-B1 SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION SABO SPA (IT) 2022-09-21 — — EP disclosed
WO-2022054601-A1 AEROSOL SPRAY HAIR COSMETIC 株式会社マンダム 2022-03-17 — — WO disclosed
US-20210324302-A1 OMEGA-3 FATTY ACID ESTER COMPOSITIONS MICELLE BIOPHARMA, INC. (US) 2021-10-21 — — US disclosed
US-20210322360-A1 SELF-MICELLIZING FATTY ACIDS AND FATTY ACID ESTER COMPOSITIONS AND THEIR USE IN THE TREATMENT OF DISEASE STATES MICELLE BIOPHARMA, INC. (US) 2021-10-21 — — US disclosed
US-20210322359-A1 SICKLE CELL DISEASE TREATMENT UTILIZING OMEGA-3 FATTY ACIDS MICELLE BIOPHARMA, INC. (US) 2021-10-21 — — US disclosed
US-11046909-B2 Omega-3 fatty acid ester compositions Omega Biopharma, Inc. (US) 2021-06-29 — — US disclosed
WO-2021059908-A1 AEROSOL SPRAY HAIRSTYLING PRODUCT 株式会社マンダム 2021-04-01 — — WO disclosed
US-10898458-B2 Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states MICELLE BIOPHARMA, INC. (US) 2021-01-26 — — US disclosed
WO-2005094777-A1 EXTERNAL PREPARATION FOR SKIN SHOWA DENKO K.K. (JP) 2005-10-13 — — WO disclosed
WO-2005095462-A1 MOISTURE RETENTION POLYMER COMPOUND SHOWA DENKO K.K. (JP) 2005-10-13 — — WO disclosed
US-20050220744-A1 Polysaccharide/functional compound complex SHOWA DENKO K.K. 2005-10-06 — — US disclosed
WO-2005092285-A1 A SKIN CARE AND COSMETIC PREPARATION CONTAINING AN INOSITOL DERIVATIVE SHOWA DENKO K.K. (JP) 2005-10-06 — — WO disclosed
WO-2005089708-A1 OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION SHOWA DENKO K.K. (JP) 2005-09-29 — — WO disclosed
EP-1541633-A1 AQUEOUS SUSPENSION OF CROSSLINKED SILICONE PARTICLES, AQUEOUS EMULSION OF OIL CONTAINING CROSSLINKED SILICONE PARTICLES, AND COSMETIC INGREDIENTS Dow Corning Toray Silicone Company, Ltd. (JP) 2005-06-15 — — EP disclosed
WO-2005034903-A1 AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER SHOWA DENKO K.K. (JP) 2005-04-21 — — WO disclosed
US-20040147647-A1 Polyorganosiloxane micro-emulsion composition and raw material for cosmetics DOW CORNING TORAY SILICONE CO., LTD. (JP) 2004-07-29 — — US disclosed
EP-1406575-A2 POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS Dow Corning Toray Silicone Co.,Ltd. Patent Department (JP) 2004-04-14 — — EP disclosed
WO-2002094213-A2 POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS DOW CORNING TORAY SILICONE CO.,LTD. (JP) 2002-11-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147647-A1 Polyorganosiloxane micro-emulsion composition and raw material for cosmetics UNG, PHOSPHO1, TPMT FAAH 741/4885CES1 1260/4885CES2 1318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback